May 22 (Reuters) - Organovo Holdings Inc ONVO.O :
* ORGANOVO UPDATES KEY CLINICAL DEVELOPMENT GOALS; COMPANY
REPORTS PRELIMINARY FISCAL FOURTH-QUARTER 2019 RESULTS
* ORGANOVO HOLDINGS INC - PRE-INVESTIGATIONAL NEW DRUG
MEETING
WITH FDA EXPECTED TO BE HELD IN CALENDAR 2020
* ORGANOVO HOLDINGS INC - PRELIMINARY FISCAL FOURTH-QUARTER
NET
LOSS WAS $7.0 MILLION, A $0.5 MILLION IMPROVEMENT OVER YEAR-AGO
PERIOD
* ORGANOVO HOLDINGS INC - PRELIMINARY FISCAL FOURTH-QUARTER
TOTAL
REVENUE WAS $0.7 MILLION, A 38 PERCENT DECREASE
* ORGANOVO HOLDINGS INC - AS OF MARCH 31, 2019, COMPANY HAD
A CASH
AND CASH EQUIVALENTS BALANCE OF $36.5 MILLION
Source text for Eikon: ID:nGNXs0Hd1
Further company coverage: ONVO.O
((Reuters.Briefs@thomsonreuters.com;))